Report Ocean introduces a fresh report examining the ‘Global Multiplex Biomarker Imaging Market’, encompassing its size, share, growth, industry trends, and forecast up to 2032. This comprehensive analysis delves into various industry components and growth patterns that offer valuable insights for anticipating the market’s future trajectory.
The multiplex biomarker imaging market will grow because of its ability to detect the presence of, severity, and exact location of chronic diseases and tumors, along with other applications. The global multiplex biomarker imaging market is projected to expand at a compound annual growth rate (CAGR) of 12.0% during the 2018-2023 period, generating a revenue of USD 523.59 Mn by 2023.
Request to Download Free Sample Copy of ‘Global Multiplex Biomarker Imaging Market’ Report: -https://reportocean.us/sample-request/report_id/IND127
The global multiplex biomarker imaging market can be segmented based on:
- Techniques – immunohistochemistry (IHC), fluorescence in situ hybridization (FISH), immunofluorescence (IF), tissue microarray (TMA), and toponome imaging system (TIS)
- Components – instruments, reagents and kits, and software
- Applications – oncology studies, drug safety, genetic characterization, and others (neurodegeneration and protein research)
- End users – research institutes, translational labs, and pharma and biopharma companies
Technique segment insights:
IHC held the largest market share (around 47%) in this segment in 2017. It is widely used in research laboratories and clinical diagnostics, owing to the advantages it offers, vis-à-vis traditional methods of enzyme staining, including specific antigen-antibody reactions. Higher incidence of chronic diseases, especially cancer, is fuelling the need for targeted treatments, thereby contributing to the growth of TMA. The market for TMA is projected to expand at a CAGR of 14.3% during the 2018-2023 period.
Component segment insights:
The instruments section held the largest market share (67%) in 2017, followed by reagents and kits. However, software is predicted to record the fastest expansion (CAGR of 15.0%) during the forecast period (2018-2023), with more automated software packages being made available to researchers. These software modules assist in the research of various diseases and improve the workflow of quantitative analysis.
Application segment insights:
Multiplex biomarker imaging products are used mostly in oncology studies. This will be followed by drug safety applications, which is expected to expand at a CAGR of 14.1% during 2018-2023.
End user segment insights:
Currently, multiplex biomarker imaging products can only be used for research purposes. Pharma and biopharma companies dominated the markets end user segment in 2017 with a share of 39%. Meanwhile, translational laboratories are projected to grow at a significant rate during the forecast period.
Regional insights:
The global multiplex biomarker imaging market can be segmented based on regions into North America, Europe, Asia-Pacific, Latin America, and the Middle East and Africa.
North America dominated the global multiplex biomarker imaging market with a share of 50% in 2017, followed by Europe with a 28% share. Asia-Pacific is expected to expand at the highest CAGR (16.0%) during 2018-2023. Across North America and Europe, companies that have software and service agreements for several years are directly selling imaging products to biopharmaceutical companies, laboratories, and academic institutions.
Companies covered:
- Thermo Fisher Scientific, Inc.
- Perkin Elmer, Inc.
- Abcam Plc.
- Bio-Rad Laboratories Inc.
- US Biomax, Inc.
- Merck KGaA
- Ventana Medical Systems, Inc.
- MicroConstants, Inc.
- Leica Biosystems Nussloch GmbH
- ToposNomos Ltd.
- Illumina, Inc.
The report further discusses the market opportunity, compound annual growth rate (CAGR) growth rate, competition, new technology innovations, market players analysis, government guidelines, export and import (EXIM) analysis, historical revenues, future forecasts etc. in the following regions and/or countries:
- North America (U.S. & Canada)
- Latin America (Brazil, Mexico, Argentina, Rest of Latin America)
- Europe (U.K., Germany, France, Italy, Spain, Hungary, Belgium, Netherlands & Luxembourg, NORDIC (Finland, Sweden, Norway, Denmark), Ireland, Switzerland, Austria, Poland, Turkey, Russia, Rest of Europe), Poland, Turkey, Russia, Rest of Europe)
- Asia-Pacific (China, India, Japan, South Korea, Singapore, Indonesia, Malaysia, Australia, New Zealand, Rest of Asia-Pacific)
- Middle East and Africa (Israel, GCC (Saudi Arabia, UAE, Bahrain, Kuwait, Qatar, Oman), North Africa, South Africa, Rest of Middle East and Africa)
Some Questions Answered in the Multiplex Biomarker Imaging Market Report:
- What is the projected size of the global Multiplex Biomarker Imaging market in 2032, and what growth rate is expected?
- What are the primary drivers of growth in the global Multiplex Biomarker Imaging industry?
- What are the major market trends that are affecting the expansion of the Multiplex Biomarker Imaging market?
- What obstacles must be overcome in order to achieve sustained growth in the Multiplex Biomarker Imaging market?
- What opportunities and threats do vendors in the global Multiplex Biomarker Imaging market face?
- What are the raw materials and manufacturing equipment used in the production of Multiplex Biomarker Imaging, and what is the manufacturing process?
- What are the different types and applications of Multiplex Biomarker Imaging, and what is the market share of each type and application?
- What factors, such as trends, challenges, and risk factors, are currently shaping the growth of the Multiplex Biomarker Imaging market?
- What factors are driving the growth of the Multiplex Biomarker Imaging market in the top regions worldwide?
- Who are the major players in the global Multiplex Biomarker Imaging market, and what strategies are they employing to succeed?
- What industrial trends, drivers, and challenges are influencing the expansion of the Multiplex Biomarker Imaging market?
- What are the main findings of a five forces analysis of the global Multiplex Biomarker Imaging market?
About Report Ocean:
We are the best market research reports provider in the industry. Report Ocean believes in providing quality reports to clients to meet the top line and bottom-line goals which will boost your market share in today’s competitive environment. Report Ocean is a ‘one-stop solution’ for individuals, organizations, and industries that are looking for innovative market research reports.